These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3970123)

  • 1. Systemic absorption and cardiovascular effects of phenylephrine eyedrops.
    Kumar V; Schoenwald RD; Chien DS; Packer AJ; Choi WW
    Am J Ophthalmol; 1985 Feb; 99(2):180-4. PubMed ID: 3970123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous vs viscous phenylephrine. I. Systemic absorption and cardiovascular effects.
    Kumar V; Schoenwald RD; Barcellos WA; Chien DS; Folk JC; Weingeist TA
    Arch Ophthalmol; 1986 Aug; 104(8):1189-91. PubMed ID: 3741249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.
    Stavert B; McGuinness MB; Harper CA; Guymer RH; Finger RP
    JAMA Ophthalmol; 2015 Jun; 133(6):647-52. PubMed ID: 25789577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of side effects from topically administered 10% phenylephrine eyedrops. A controlled study.
    Brown MM; Brown GC; Spaeth GL
    Arch Ophthalmol; 1980 Mar; 98(3):487-9. PubMed ID: 7362505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac effects of different eyedrop preparations of timolol in rabbits.
    Järvinen K; Urtti A
    Curr Eye Res; 1992 May; 11(5):469-73. PubMed ID: 1606842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled retrospective study of the effects of eyedrops containing phenylephrine hydrochloride and scopolamine hydrobromide on mean arterial blood pressure in anesthetized dogs.
    Martin-Flores M; Mercure-McKenzie TM; Campoy L; Erb HN; Ludders JW; Gleed RD
    Am J Vet Res; 2010 Dec; 71(12):1407-12. PubMed ID: 21117990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine.
    Ianchulev T; Weinreb R; Tsai JC; Lin S; Pasquale LR
    Ther Deliv; 2018 Jan; 9(1):17-27. PubMed ID: 29076771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combined 1% cyclopentolate-10% phenylephrine eye drops on systemic blood pressure of glaucoma patients.
    Epstein DL; Murphy E
    Ann Ophthalmol; 1981 Jun; 13(6):735-6. PubMed ID: 7258971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The phenylephrine concentration-response relationship for blood pressure after nasal delivery in children.
    Anderson BJ; Christensen LK; Armstead VE; Bilyeu DP; Johnson KE; Friesen RH
    Paediatr Anaesth; 2017 Oct; 27(10):1050-1055. PubMed ID: 28868789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical 2.5% and 5% phenylephrine: comparison of effects on heart rate and blood pressure.
    Hakim OJ; Orton RB; Cadera W
    Can J Ophthalmol; 1990 Dec; 25(7):336-9. PubMed ID: 2090337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic responses and plasma phenylephrine concentrations associated with intranasal phenylephrine in children.
    Christensen LK; Armstead VE; Bilyeu DP; Johnson KE; Friesen RH
    Paediatr Anaesth; 2017 Jul; 27(7):768-773. PubMed ID: 28504321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography.
    Cagini C; Caricato A; Tosi G; Pascale A; Cesari C; Fiore T
    Eur J Ophthalmol; 2014; 24(5):728-34. PubMed ID: 24557758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ophthalmic epinephrine, phenylephrine, and pilocarpine affect the systemic absorption of ocularly applied timolol.
    Urtti A; Kyyrönen K
    J Ocul Pharmacol; 1989; 5(2):127-32. PubMed ID: 2754297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cardiovascular effects of 2.5% phenylephrine and 10% phenylephrine during ophthalmic surgery.
    Malhotra R; Banerjee G; Brampton W; Price NC
    Eye (Lond); 1998; 12 ( Pt 6)():973-5. PubMed ID: 10325999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the therapeutic index of topical phenylephrine by reducing drop volume.
    Brown RH; Wood TS; Lynch MG; Schoenwald RD; Chien DS; Jennings LW
    Ophthalmology; 1987 Jul; 94(7):847-50. PubMed ID: 3658353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorometric determination of phenylephrine hydrochloride by liquid chromatography in human plasma.
    Chien DS; Schoenwald RD
    J Pharm Sci; 1985 May; 74(5):562-4. PubMed ID: 4020635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylephrine eye drops in ophthalmic surgery--a clinical study on cardiovascular effects.
    Chin KW; Law NM; Chin MK
    Med J Malaysia; 1994 Jun; 49(2):158-63. PubMed ID: 8090095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duration and long-term efficacy of phenylephrine-induced reduction in the systemic absorption of ophthalmic timolol in rabbits.
    Järvinen K; Urtti A
    J Ocul Pharmacol; 1992; 8(2):91-8. PubMed ID: 1506759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.